Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

New Academic Head at South Campus to expand distance learning programmes into the global arena
2016-02-10

“Critical area of focus: Diversify provision, based on open learning principles, to improve learning opportunities across the post-school education and training sector” - SA Department of Higher Education and Training Strategic Plan 2015/16-2019/20

Open and distance learning (ODL) programmes will play a critical role in shaping the landscape of higher education. Not only does the South African Department of Higher Education and Training emphasise the importance of ODL, it is also contained within the United Nations’ Sustainable Development Goals. And now the University of the Free State (UFS) is becoming a major role player in the field through the cutting-edge ODL programmes offered by the South Campus.

Description: Jean Grundling  Tags: Jean Grundling

Jean Grundling has recently been appointed as the Academic Head of the South Campus.

At the helm of these programmes is the recently-appointed Academic Head of the South Campus: Jean Grundling. According to the new organisational structure of the South Campus, the Academic Head reports directly to the Campus Principal: Dr Daniella Coetzee.

“My role,” says Grundling, “focuses on developing and monitoring processes that will enable effective and efficient implementation of the three pillars of ODL.” These three pillars consist of:

• the design and development of quality learner-centred learning materials and tools during their ODL journeys;
• the selection, appointment, and development of competent facilitators to guide, coach, tutor, and support students; and
• the integration of administrative processes that will enable and support students to study at their own pace, place, and in their own time.

“Goal 4: Ensure inclusive and equitable quality education, and promote lifelong learning opportunities for all.”
United Nations Sustainable Development Goals

As part of her personal vision, Grundling would like to see the South Campus grow and develop into an institution that offers quality ODL programmes not only nationally, but globally. “I would like the South Campus to become an agent of social transformation in South Africa.”

Ultimately, Grundling’s wish is for the South Campus to contribute to the development and empowerment of people so that they can play a positive role in society.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept